Carregant...
Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors
BACKGROUND: Approximately 50% of cancer patients eventually develop a syndrome of prolonged weight loss (cachexia), which may contribute to primary resistance to immune checkpoint inhibitors (ICI). This study utilised radiomics analysis of (18)F-FDG-PET/CT images to predict risk of cachexia that can...
Guardat en:
| Publicat a: | Br J Cancer |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292339/ https://ncbi.nlm.nih.gov/pubmed/33828255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01375-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|